All Videos

Nanette Silverberg, MD, discusses new treatments for pediatric vitiligo, including JAK inhibitors and surgical advancements.

Proper nutrition and nutraceuticals can help to manage skin conditions such as acne, eczema, and psoriasis.

A patient-centered approach ensures that hair loss treatments align with individual goals and medical history.

His presentation at South Beach Symposium will feature Zirwas’ insights on JAK inhibitors, eczema treatments, and emerging therapies.

“The most important tip as a physician, when you talk to the patient, sit down. Even if you sit down for 5 minutes, it's worth almost 5 hours,’ Leon Kircik, MD, said in his interview with Dermatology Times at SBS 2025.

Nada Elbuluk, MD, MSc, emphasizes that medical treatments remain first-line for vitiligo, but stable cases may benefit from surgical options.

Michael Gold, MD, shares why the South Beach Symposium remains a must-attend legacy event for dermatologists, blending education and innovation.

According to Silverberg, emotional resilience, social support, and purposeful activities help adolescents cope with acne-related stress.

Nanette Silverberg, MD, highlights new dermatology advancements and the significance of conferences like MOPD in shaping the future of treatment.

Dermatology Times staff will be onsite covering SBS 2025 with expert insights, interviews, and breaking news.

In an interview ahead of the main event, Ablon shared her excitement for SBS and listening in on presentations from industry leaders.

The new dose offers a more tailored and convenient option for patients with inflammatory conditions.

Cheri Frey, MD, discusses how emerging laser technologies are advancing melanocyte-sparing treatments while developing more precise targeting capabilities and enhanced safety features for diverse skin types.

A panelist discusses how setting realistic expectations about treatment outcomes and following proper protocols around laser settings, skin typing, and aftercare are essential for preventing complications and achieving optimal results.

Cheri Frey, MD, discusses how combining different laser treatments with traditional therapies can effectively target both the vascular and inflammatory components of rosacea while minimizing adverse effects and recovery time.

There are numerous ways for dermatologists to get involved in initiatives from the Skin Cancer Foundation, according to Becky Kamowitz.

TJ Chao, MPAS, PA-C, discusses tips for educating patients and raising awareness about prurigo nodularis, focusing on the importance of informing patients about the role of systemic treatments and empowering them to make informed decisions about their care.

TJ Chao, MPAS, PA-C, discusses how to approach conversations with patients about starting systemic therapy for prurigo nodularis, emphasizing the importance of setting realistic treatment expectations, promoting long-term adherence, and providing tips for managing biologic agents administered on a bimonthly or monthly basis.

“The Big See” campaign and the Seal of Recommendation program are just 2 examples of initiatives led by the Skin Cancer Foundation.

The Foundation’s extensive library includes brochures, magazines, and posters to promote education among dermatologists and patients.

A panelist discusses how laser treatments demonstrate a strong safety profile and proven efficacy for patients with acne, with clinical studies showing significant reduction in both inflammatory and noninflammatory lesions.

A panelist discusses how laser therapy serves as both a stand-alone alternative and complementary treatment to traditional acne therapies, providing patients with expanded options for managing their skin condition.

A panelist discusses how laser therapy can be customized for different skin types and acne severities through adjustable wavelengths and treatment protocols, offering effective solutions across the spectrum of acne presentations.

One of the Foundation’s top initiatives is its mobile skin cancer screening program, “Destination Healthy Skin.”

A panelist discusses how combining laser therapy with other treatment modalities, such as topical medications, phototherapy, and systemic agents, can produce synergistic effects and better clinical outcomes for resistant skin conditions.

A panelist discusses how laser therapy protocols should be customized based on patients’ financial resources, previous treatment experiences, and commitment level to ensure optimal adherence and therapeutic success.

A panelist discusses how targeted laser therapy offers promising treatment outcomes for chronic skin conditions, such as eczema, psoriasis, and vitiligo, by reducing inflammation, stimulating melanin production, and promoting skin healing through controlled light exposure.

A panelist discusses how the advent of targeted systemic therapies such as dupilumab and nemolizumab has transformed the treatment landscape for prurigo nodularis, offering more effective options for breaking the itch-scratch cycle while maintaining favorable safety profiles compared with traditional systemic treatments.

“As good as we saw results in 1 month, we think we'll see even more remarkable results over the 6 months of treatment,” Edelson said in an interview with Dermatology Times.

Jon Edelson, MD, CEO of Eirion, confirms that topical ET-02 is a completely new approach to treating this type of hair loss.